Secondary malignant neoplasm of small intestine refers to the presence of cancerous cells in the small intestine that have metastasized from another primary site. This condition is clinically significant as it indicates advanced disease and requires accurate coding for effective diagnosis, documentation, medical billing, and public health reporting. The ICD-10 Code C78.4 facilitates precise identification of this condition, ensuring appropriate treatment and resource allocation.
ICD-10 Code C78.4 represents secondary malignant neoplasm of the small intestine, indicating that cancer has spread to this area from another primary tumor. This code is essential for clinical documentation and billing, particularly when managing patients with metastatic disease, as it helps in tracking treatment outcomes and resource utilization.
Secondary malignant neoplasm of small intestine occurs when cancer cells from a primary tumor spread to the small intestine, often leading to significant complications. This condition necessitates prompt medical attention due to its association with advanced cancer stages and potential for severe gastrointestinal symptoms.
ICD-10 Code C78.4 is utilized in SOAP notes to document the presence of secondary malignant neoplasm of the small intestine. It plays a crucial role in capturing patient symptoms, assessments, and treatment plans, relevant in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C78.4 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of secondary malignant neoplasm of the small intestine. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of secondary malignant neoplasm of small intestine often requires hospitalization due to the complexity of the condition. Treatment approaches may include chemotherapy, targeted therapy, and supportive care.
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C78.4 is critical in medical billing, particularly in hospital and oncology settings, to ensure accurate claims processing.
CPT Code | Description |
---|---|
96413 | Chemotherapy administration, intravenous, push, single or initial substance |
99223 | Initial hospital care, typically 70 minutes or more |
96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis |
99232 | Subsequent hospital care, typically 25 minutes |
Common Questions About Using ICD-10 Code C78.4 for Secondary malignant neoplasm of small intestine
What are the common symptoms of secondary malignant neoplasm of small intestine?
Common symptoms include abdominal pain, weight loss, nausea, vomiting, and gastrointestinal bleeding. These symptoms may indicate advanced disease and require prompt medical evaluation.
How is ICD-10 Code C78.4 used in billing?
ICD-10 Code C78.4 is used in billing to document the diagnosis of secondary malignant neoplasm of small intestine, ensuring accurate claims processing and reimbursement for treatment provided.
What is the prognosis for patients with secondary malignant neoplasm of small intestine?
The prognosis for patients with secondary malignant neoplasm of small intestine is generally poor, as it often indicates advanced cancer. Treatment focuses on symptom management and palliative care.
Can secondary malignant neoplasm of small intestine be treated?
Treatment options may include chemotherapy, targeted therapy, and supportive care. The approach depends on the primary cancer type and the extent of metastasis.
Clinical Notes
SOAP notes
DAP notes
AI medical notes